Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Keiko, Nibu"'
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 58:720-725
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98075f9522854514ddc9bfc87d2c6fbc
https://doi.org/10.3925/jjtc.58.720
https://doi.org/10.3925/jjtc.58.720
Autor:
Fumio Yanai, Hidetaka Akiyoshi, Shinichi Hirose, Takeo Fukushima, Takahito Inoue, Yuko Nomura, Hitoshi Tsugu, Keiko Nibu, Sawa Yasumoto
Publikováno v:
Pediatrics International. 51:337-341
Background: Most infants with brain tumor may have a poor prognosis. The aim of the present study was to retrospectively analyze the survival and outcome with regard to mental and physical development in 11 subjects with brain tumor; these tumors wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33ece0aea35504f9834b73730fc558b7
https://doi.org/10.1111/j.1442-200x.2008.02760.x
https://doi.org/10.1111/j.1442-200x.2008.02760.x
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 54:378-385
厚生労働省は2006年にアルブミン使用量/赤血球製剤使用量（At/RBCt）が2以下となる血液製剤の使用を提案した．福岡大学病院ではこの10年余り，At/RBCtは4前後であり，アルブミンの使用過
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0dd318ff363574fb20f318735d88ca68
https://doi.org/10.3925/jjtc.54.378
https://doi.org/10.3925/jjtc.54.378
Publikováno v:
Journal of the Japan Society of Blood Transfusion. 51:430-434
We analyzed the usage of blood components at an Emergency and Critical Care Unit for 2 years, from 2001 to 2002. A total of 531 patients who received blood transfusions were divided into two groups, injured (group I; n=137 patients) and uninjured (gr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a45ce2bec681ff1736a8b5c7930bfa60
https://doi.org/10.3925/jjtc1958.51.430
https://doi.org/10.3925/jjtc1958.51.430
Autor:
Yoko Yoshiura, Keiko Nibu, Midori Kumagawa, Kuninori Kubota, Yuriko Nomaguchi, Masatoshi Naito
Publikováno v:
Journal of the Japan Society of Blood Transfusion. 50:693-698
We analyzed the use of recombinant erythropoietin (r-EPO) among 368 patients, each of whom had donated more than 800ml for later autologous transfusion during orthopedic surgery. Of the 269 patients who would have required r-EPO according to the heal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::211c0c5c890297f17f67a187d65763c2
https://doi.org/10.3925/jjtc1958.50.693
https://doi.org/10.3925/jjtc1958.50.693
Autor:
Yoshiaki Maeda, Keiko Nibu
Publikováno v:
Journal of the Japan Society of Blood Transfusion. 50:68-72
We evaluated the practical education of 5th grader medical students at a regional blood center concerning various aspects of blood transfusion.Practical education consisted of observation of voluntary blood donation, assistance in publicity of blood
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bf9d8e53145d5ec628a5754a3f103fa
https://doi.org/10.3925/jjtc1958.50.68
https://doi.org/10.3925/jjtc1958.50.68
The evaluation of fresh frozen plasma and albumin usage in the major hospitals at Fukuoka Prefecture
Publikováno v:
Journal of the Japan Society of Blood Transfusion. 47:659-662
We undertook an investigation of blood components and albumin used in sixty-eight major hospitals at Fukuoka prefecture during the first six months of 1998. An evaluation of the share of FFP and Alb in the total blood products consumption was perform
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78c0f2d8a4d261715d409a3be959f6c2
https://doi.org/10.3925/jjtc1958.47.659
https://doi.org/10.3925/jjtc1958.47.659
Autor:
Akihisa Mitsudome, Fumio Yanai, Nobuko Kanai, Takeo Kubota, Shinichi Hirose, Kenji Izuhara, Tokio Tani, Keiko Nibu
Publikováno v:
Human Genetics. 104:36-42
We report here that a defect of the interleukin common gamma subunit (gamma c) in X-linked severe combined immunodeficiency (XSCID) previously known as a missense mutation resulted instead in exon skipping in a Japanese XSCID patient. The phenotype o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f613d6b7342ac590761610e3408136a4
https://doi.org/10.1007/s004390050907
https://doi.org/10.1007/s004390050907
Autor:
Toshiro Inoue, Nobuyuki Yoshida, Hiromichi Take, Takanobu Ishihara, Haruhiko Eguchi, Akinobu Matsuzaki, Eiichi Ishii, Sumio Miyazaki, Fumio Yanai, Kohji Ueda, Hideko Tasaka, Kazuaki Miyake, Chizuru Tsuboi, Keiko Nibu, Jun Okamura
Publikováno v:
Medical and Pediatric Oncology. 26:10-19
A total of 125 children, who were diagnosed as having high-risk acute lymphoblastic leukemia (ALL), were treated with two consecutive protocols designated as AL851 (1985-1988) and ALHR88 (1988-1990). All patients received induction therapy consisting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59b350c64f10a95bc79163b6d9925b8d
https://doi.org/10.1002/(sici)1096-911x(199601)26:1<10::aid-mpo2>3.0.co
https://doi.org/10.1002/(sici)1096-911x(199601)26:1<10::aid-mpo2>3.0.co
Autor:
Jun Okamura, Yoshiko Ikuno, Hideko Tasaka, Hiromichi Take, Fumio Yanai, Akinobu Matsuzaki, Sumio Miyazaki, Haruhiko Eguchi, Hiroko Inada, Keiko Nibu, Hideki Nakayama, Ryo Sakai, Hiroyuki Koga
Publikováno v:
Pediatric Hematology and Oncology. 12:251-258
We evaluated the efficacy and toxicity of aclarubicin for acute non-lymphocytic leukemia (ANLL) refractory to daunorubicin in childhood. Twenty-four patients were treated with aclarubicin and prednisolone with or without 6-mercaptopurine and behenoyl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc9c487b5c20df432769f8be2953c3de
https://doi.org/10.3109/08880019509029566
https://doi.org/10.3109/08880019509029566